Kainan Wang

Dalian, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Optimizing endocrine adjuvant therapy in HR+/HER2- breast cancer: supplemental strategies and innovations.

Optimizing endocrine adjuvant therapy in HR+/HER2- breast cancer: supplemental strategies and innovations.

Journal: Annals of medicine and surgery (2012)

Published: May 15, 2025

Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients.

Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients.

Journal: Therapeutic advances in medical oncology

Published: November 19, 2024

RBM7 deficiency promotes breast cancer metastasis by coordinating MFGE8 splicing switch and NF-kB pathway.

RBM7 deficiency promotes breast cancer metastasis by coordinating MFGE8 splicing switch and NF-kB pathway.

Journal: eLife

Published: July 12, 2024

Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes.

Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes.

Journal: Breast (Edinburgh, Scotland)

Published: July 08, 2024

The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019.

The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019.

Journal: International journal of public health

Published: April 04, 2024

Recent progress of CDK4/6 inhibitors' current practice in breast cancer.

Recent progress of CDK4/6 inhibitors' current practice in breast cancer.

Journal: Cancer gene therapy

Published: December 20, 2023

PARP Inhibitor for Neoadjuvant Therapy in HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety.

PARP Inhibitor for Neoadjuvant Therapy in HER2-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Journal: Clinical breast cancer

Published: September 11, 2023

Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report.

Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report.

Journal: Frontiers in oncology

Published: November 15, 2022

A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer.

A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: July 05, 2022

A novel mutant PIK3R1EY451delinsD breast cancer patient resistant to HER2-targeted therapy treated with everolimus: a case report.

A novel mutant PIK3R1EY451delinsD breast cancer patient resistant to HER2-targeted therapy treated with everolimus: a case report.

Journal: Molecular biology reports

Published: January 02, 2022

Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer.

Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer.

Journal: Frontiers in surgery

Published: December 17, 2021

A potential role for metastasis-associated in colon cancer 1 (MACC1) as a pan-cancer prognostic and immunological biomarker.

A potential role for metastasis-associated in colon cancer 1 (MACC1) as a pan-cancer prognostic and immunological biomarker.

Journal: Mathematical biosciences and engineering : MBE

Published: November 24, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026